medical-device-investing AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study
pharmaceutical-investing ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872
Jura Announces Dismissal in Full of PEL's Appeal against certain reliefs granted in the Settlement Agreement Arbitral Award